Literature DB >> 10625707

Widening gap of stroke between east and west. Eight-year trends in occurrence and risk factors in Russia and Sweden.

B Stegmayr1, T Vinogradova, S Malyutina, M Peltonen, Y Nikitin, K Asplund.   

Abstract

BACKGROUND AND
PURPOSE: Stroke is declining in most of the western and northern European countries, whereas no such decline is seen in eastern Europe. The aim of this study was to investigate trends in stroke attack rates and 28-day case fatality and risk factor levels in Novosibirsk, Siberia, and northern Sweden during 1987-1994.
METHODS: Within the World Health Organization Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) Project, acute stroke events and 28-day case fatality were registered in a standardized way in men and women aged 35 to 69 years. Cardiovascular risk factors were monitored in randomly selected men and women in the group aged 35 to 64 years in 1985-1986 and 1994-1995.
RESULTS: Stroke attack rates increased significantly from 430 per 100 000 to 660 (P=0.005) in men in Novosibirsk and from 298 to 500 (P=0.02) in women. In northern Sweden, stroke attack rates varied between 244 and 303 per 100 000 in men and from 117 to 157 in women, with a small increasing trend in women (P=0.03). The mortality rates were 5 times higher in Novosibirsk, and the case fatality was significantly lower in northern Sweden (P=0.0001). The risk factor surveys showed significantly higher blood pressure, overweight, and more smoking men in Novosibirsk, while northern Sweden had higher cholesterol levels and more smoking women. Most risk factors showed stable or improving patterns over time.
CONCLUSIONS: Large differences in both attack rates and case fatality account for the large and widening gap in stroke mortality between Russia and Sweden. A higher prevalence of hypertension in Russia may explain much of the differences in stroke occurrence. In Russia, a marked increase in attack rates has occurred despite stable or improving patterns of conventional cardiovascular risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10625707     DOI: 10.1161/01.str.31.1.2

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  The trend of cardiovascular disease in immigrants in Sweden.

Authors:  M Gadd; S-E Johansson; J Sundquist; P Wändell
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Stroke in patients with diabetes mellitus: a study from North Western Nigeria.

Authors:  Lukman Owolabi; Mansur Nagode; Aliyu Ibrahim; Andrew Uloko; Ibrahim Gezawa; Mohammad Datti
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

Review 3.  Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.

Authors:  Doosup Shin; Yun Hwan Oh; Chun-Sick Eom; Sang Min Park
Journal:  J Neurol       Date:  2014-01-30       Impact factor: 4.849

Review 4.  Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies.

Authors:  Kyu-Sun Choi; Hyun Jung Kim; Hyoung-Joon Chun; Jae Min Kim; Hyeong-Joong Yi; Jin-Hwan Cheong; Choong-Hyun Kim; Suck-Jun Oh; Yong Ko; Young-Soo Kim; Koang-Hum Bak; Je-Il Ryu; Wonhee Kim; Taeho Lim; Hyeong Sik Ahn; Il Min Ahn; Seon-Heui Lee
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

5.  Factors associated with death and predictors of one-month mortality from stroke in Kano, Northwestern Nigeria.

Authors:  Owolabi Lukman Femi; Nagoda Mansur
Journal:  J Neurosci Rural Pract       Date:  2013-08

6.  Stroke in urban and rural populations in north-east Bulgaria: incidence and case fatality findings from a 'hot pursuit' study.

Authors:  John Powles; Philip Kirov; Nevijana Feschieva; Marin Stanoev; Virginia Atanasova
Journal:  BMC Public Health       Date:  2002-09-25       Impact factor: 3.295

7.  Prevalence of cardiometabolic risk factors and selected cardiovascular diseases in hypertensive and normotensive participants in the adult Polish population: The WOBASZ II study.

Authors:  Arkadiusz Niklas; Justyna Marcinkowska; Magdalena Kozela; Andrzej Pająk; Tomasz Zdrojewski; Wojciech Drygas; Aleksandra Piwońska; Wojciech Bielecki; Krystyna Kozakiewicz; Andrzej Tykarski
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.